These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 17959980
1. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R. Anesth Analg; 2007 Nov; 105(5):1442-8, table of contents. PubMed ID: 17959980 [Abstract] [Full Text] [Related]
2. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Gaertner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Ostgathe C, Elsner F, Sabatowski R. Acta Anaesthesiol Scand; 2006 Jul; 50(6):664-72. PubMed ID: 16987359 [Abstract] [Full Text] [Related]
3. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function. Shmygalev S, Damm M, Weckbecker K, Berghaus G, Petzke F, Sabatowski R. Drug Alcohol Depend; 2011 Sep 01; 117(2-3):190-7. PubMed ID: 21353749 [Abstract] [Full Text] [Related]
6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pain Pract; 2008 Sep 01; 8(4):287-313. PubMed ID: 18503626 [Abstract] [Full Text] [Related]
7. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study. Sittl R, Nuijten M, Nautrup BP. Clin Ther; 2005 Jul 01; 27(7):1022-31. PubMed ID: 16154481 [Abstract] [Full Text] [Related]
8. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. Sittl R, Likar R, Nautrup BP. Clin Ther; 2005 Feb 01; 27(2):225-37. PubMed ID: 15811486 [Abstract] [Full Text] [Related]
9. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine. Wirz S, Wittmann M, Schenk M, Schroeck A, Schaefer N, Mueller M, Standop J, Kloecker N, Nadstawek J. Eur J Pain; 2009 Aug 01; 13(7):737-43. PubMed ID: 18977159 [Abstract] [Full Text] [Related]
10. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Griessinger N, Sittl R, Likar R. Curr Med Res Opin; 2005 Aug 01; 21(8):1147-56. PubMed ID: 16083522 [Abstract] [Full Text] [Related]
11. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR. Clin Ther; 2007 Oct 01; 29(10):2179-93. PubMed ID: 18042474 [Abstract] [Full Text] [Related]
12. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain]. Tschirner M, Ritzdorf I, Brünjes R. MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217 [Abstract] [Full Text] [Related]
13. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude. Baewert A, Gombas W, Schindler SD, Peternell-Moelzer A, Eder H, Jagsch R, Fischer G. Eur Addict Res; 2007 Sep 18; 13(3):127-35. PubMed ID: 17570908 [Abstract] [Full Text] [Related]
14. [The transdermal 7-day buprenorphine patch--an effective and safe treatment option, if tramadol or tilidate/naloxone is insufficient. Results of a non-interventional study]. Schutter U, Ritzdorf I, Heckes B. MMW Fortschr Med; 2010 Jul 01; 152 Suppl 2():62-9. PubMed ID: 21591321 [Abstract] [Full Text] [Related]
15. [Opioids in the management of chronic pain and driving ability]. Sabatowski R, Kaiser U, Gossrau G. Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Jun 01; 45(6):384-5. PubMed ID: 20539964 [Abstract] [Full Text] [Related]
16. [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac]. Böhme K, Heckes B, Thomitzek K. MMW Fortschr Med; 2011 Jan 13; 152 Suppl 4():125-32. PubMed ID: 21598463 [Abstract] [Full Text] [Related]
17. [Influence of opioids on the psychomotor ability of patients in chronic pain]. Strumpf M, Willweber-Strumpf A. Dtsch Med Wochenschr; 2008 Jun 13; 133 Suppl 2():S36-7. PubMed ID: 18548368 [Abstract] [Full Text] [Related]
18. [Opioids and driving ability -- a problem unsolved?]. Sabatowski R, Berghaus G, Strumpf M, Radbruch L. Dtsch Med Wochenschr; 2003 Feb 14; 128(7):337-41. PubMed ID: 12584661 [No Abstract] [Full Text] [Related]
19. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old. Gianni W, Madaio AR, Ceci M, Benincasa E, Conati G, Franchi F, Galetti G, Nieddu A, Salani B, Zuccaro SM. J Pain Symptom Manage; 2011 Apr 14; 41(4):707-14. PubMed ID: 21145700 [Abstract] [Full Text] [Related]
20. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Sjøgren P, Christrup LL, Petersen MA, Højsted J. Eur J Pain; 2005 Aug 14; 9(4):453-62. PubMed ID: 15979026 [Abstract] [Full Text] [Related] Page: [Next] [New Search]